Current Porfolio

Current Portfolio

Go to the web


Cancer molecular diagnostics for early screening and diagnosis. Colofast: best in class blood...

Go to the web

Aglaris Cell

Developing a cell expansion platform for automated mesenquimal and T-cell culture...

Go to the web


First-in-class, innovative therapeutics for the treatment of Rare and Ultra-Rare Diseases.

Go to the web

Additum Blockchain

Exploring blockchain technology to improve efficiency, safety and patient value based healthcare.

Go to the web


Blood based biomarkers for early diagnosis of Alzheimer Disease. First product APOE4 test.

Go to the web


The company designs, manufactures and sells a proprietary portfolio of innovative...

Go to the web


Developing a proprietary technology with subfemtogram ultrasensibility for protein...

Go to the web

OWL Metabolomics

Metabolomic platform with first marketed non invasive diagnostic LDT for NASH.

Go to the web


dedicated PET & Molecular Imaging for Breast Cancer, Neurodegeneration and Surgery.

Go to the web

Venter Pharma

Market stage diagnostic drug for hypolactasia.

Go to the web

Green Molecular

Pterostilbene formulations for derma and oncology

Historical Portfolio

Go to the web

Health In Code

Market stage company focused on molecular genetic diagnosis of familial cardiac diseases.

Go to the web

Iden Technologies

Proprietary technology platform for the evelopment of biostimulants and biopesticides.

Go to the web

TCD Pharma

First in class small molecule for the targeted treatment of solid tumors.

Go to the web

nLife Therapeutics

Discovery and development of oligonucleotides as therapeutic agents.

Go to the web

Raman Health Technologies

New non invasive diagnostic technology platform based on Raman laser and Infrarred...

Venture Capital

Advisory Firm

Early Stage Investments